U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089862) titled 'INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)' on July 22.
Brief Summary: This project aims to evaluate the safety and efficacy of the antiplatelet regimen combining indobufen and clopidogrel in preventing ischemic events after stent-assisted coiling embolization and flow diverter implantation for intracranial aneurysms.
Using a randomization system, patients with unruptured intracranial aneurysms scheduled for interventional treatment will be divided into an experimental group and a control group. Patients in the experimental group will be required to take indobufen (100 mg twice dail...